Investor Presentaiton

Pharma Sales per capita (USD) II Key Investment Highlights 2 Attractive Industry Dynamics (I/III) Low healthcare and pharmaceutical expenditure with unparalleled growth potential Health Expenditure per capita (USD) 1,200 1,000 800 600 400 Health Expenditure per capita vs GDP per capita (USD) - 2018 900 800 700 600 500 400 300 200 100 Brazil Russia Healthcare Sector Overview Healthcare Expenditure % of GDP (2018) Egyptian Household Expenditure Breakdown (2018) 6.3% South Africa Iran Malaysia 4.2% Turkey Algeria Indonesia India Philippines 0 Pakistan' Egypt 0 2,000 4,000 6,000 8,000 10,000 12,000 GDP per capita (USD) 10.6% EM Average Global Average Others, 30% Healthcare 8% F&B 43% Housing & utilities, 18% Healthcare Expenditure constitutes low contribution to the Egyptian Household Expenditure Egypt's Health Expenditure per capita unjustifiably lags emerging markets standards Pharmaceutical Sales per Capita Vs GDP per Capita 2018 Germany Pharmaceutical Sector Overview Pharmaceutical Sales per Capita (USD) 2018 322 USA 235 Avg. Egyptians pay USD4.0/EGP73- per month on pharmaceuticals products, among the lowest countries globally Pharmaceutical Egyptian Market Key Themes Among the lowest healthcare and pharmaceutical expenditure across MENA and Emerging markets UK Canada Netherlands 110 99 95 66 51 28 15 UAE Hungary Kuwait 200 Tunisia Oman, Saudi Arabia Egypt India Morogeria 10,000 20,000 40,000 50,000 60,000 30,000 GDP per capita (USD) Pharmaceutical Sales per Capita is low with potential growth on the back of projected increase in GDP per Capita Source: BMI, EIU, CAPMAS, IMS Note(1): Egyptian Pharmaceutical Sales per capita figures are extracted from IMS report ibnsinapharma Among the cheapest countries in terms of medicine cost to end user Among the lowest medicine pocket share contribution to the household expenditure 12

View entire presentation